Journal
JOURNAL OF CLINICAL MEDICINE
Volume 11, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/jcm11041089
Keywords
celiac disease; juvenile idiopathic arthritis; pediatric systemic lupus erythematosus; juvenile dermatomyositis; systemic scleroderma; screening; prevalence
Categories
Funding
- Nazarbayev University Faculty Development Competitive Research Grant [2020-2022, 240919FD3912]
- Nazarbayev University Social Policy Grant
Ask authors/readers for more resources
This article reviews and analyzes clinical studies on celiac disease (CD) among children with juvenile idiopathic arthritis (JIA). The findings suggest a high prevalence of CD in JIA patients, particularly in those who are asymptomatic. However, there is no evidence supporting periodic CD screening for children with other pediatric rheumatic diseases.
Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3-3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available